← All Carmell CORP filings

Carmell CORP 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

CTCX
Carmell CORP
10-K/A: Longevity Health Holdings Faces Delisting Threat Amidst Significant Losses and Strategic Shift to Bio-Aesthetics
Longevity Health Holdings, Inc. filed an amended annual report revealing substantial net losses, negative working capital, and ongoing Nasdaq delisting challenges, despite recent capital raises and a strategic pivot to cosmetic bio-aesthetics.
CTCX
Carmell CORP
10-K: Longevity Health Holdings Reports 2024 Results, Focuses on Bio-Aesthetics and Navigates Financial Challenges
Longevity Health Holdings, Inc. reports its 2024 financial results, highlighting a strategic shift towards bio-aesthetics and addressing concerns about its ability to continue as a going concern.
CTCX
Carmell CORP
10-K/A: Carmell Corporation Files Amended 10-K to Include Part III Information and Updated Certifications
Carmell Corporation has filed an amendment to its annual report to include information about directors, executive compensation, and other corporate governance matters, as well as updated certifications from its CEO and CFO.
CTCX
Carmell CORP
10-K: Carmell Corporation Outlines Securities and Corporate Governance in 10-K Filing
Carmell Corporation's 10-K filing details the company's registered securities, including common stock and warrants, and outlines key corporate governance provisions.